IRIS
POLONI, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.218
EU - Europa 6.203
AS - Asia 5.203
SA - Sud America 1.429
Continente sconosciuto - Info sul continente non disponibili 575
AF - Africa 334
OC - Oceania 16
AN - Antartide 1
Totale 26.979
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.815
SG - Singapore 1.588
IT - Italia 1.455
VN - Vietnam 1.183
BR - Brasile 1.126
RU - Federazione Russa 1.040
CN - Cina 846
UA - Ucraina 791
DE - Germania 517
IE - Irlanda 483
SE - Svezia 440
HK - Hong Kong 418
FR - Francia 345
TR - Turchia 336
FI - Finlandia 302
DK - Danimarca 290
GB - Regno Unito 232
CA - Canada 188
KR - Corea 167
IN - India 152
CI - Costa d'Avorio 115
BD - Bangladesh 107
AR - Argentina 100
MA - Marocco 76
NL - Olanda 76
MX - Messico 71
IQ - Iraq 63
JP - Giappone 54
PL - Polonia 51
CO - Colombia 47
ZA - Sudafrica 46
AT - Austria 41
EC - Ecuador 41
ID - Indonesia 39
VE - Venezuela 38
ES - Italia 31
PK - Pakistan 31
UZ - Uzbekistan 31
IL - Israele 26
BE - Belgio 25
GT - Guatemala 25
PY - Paraguay 24
TN - Tunisia 23
CL - Cile 21
CR - Costa Rica 21
CW - ???statistics.table.value.countryCode.CW??? 21
EU - Europa 19
AE - Emirati Arabi Uniti 18
HN - Honduras 17
SC - Seychelles 17
DZ - Algeria 16
PE - Perù 16
PH - Filippine 16
AU - Australia 15
MY - Malesia 15
HU - Ungheria 14
LT - Lituania 14
PR - Porto Rico 14
SV - El Salvador 13
AZ - Azerbaigian 12
EG - Egitto 12
KE - Kenya 12
SA - Arabia Saudita 12
TT - Trinidad e Tobago 12
JO - Giordania 11
GP - Guadalupe 9
NI - Nicaragua 9
UY - Uruguay 9
CH - Svizzera 8
JM - Giamaica 8
BG - Bulgaria 7
IR - Iran 7
KZ - Kazakistan 7
TW - Taiwan 7
BH - Bahrain 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
LB - Libano 6
TH - Thailandia 6
AL - Albania 5
BO - Bolivia 5
KG - Kirghizistan 5
NP - Nepal 5
SN - Senegal 5
EE - Estonia 4
KW - Kuwait 4
MN - Mongolia 4
OM - Oman 4
PS - Palestinian Territory 4
RO - Romania 4
BZ - Belize 3
GA - Gabon 3
HR - Croazia 3
MD - Moldavia 3
PT - Portogallo 3
AM - Armenia 2
DM - Dominica 2
ET - Etiopia 2
GY - Guiana 2
MQ - Martinica 2
Totale 26.408
Salva come PNG Salva come JPEG
Città #
Ashburn 2.071
Singapore 931
Jacksonville 824
Chandler 752
Council Bluffs 665
Fairfield 620
Dallas 603
San Jose 584
Dublin 482
Boardman 472
Hong Kong 399
Ho Chi Minh City 396
New York 353
Des Moines 337
Wilmington 336
Hanoi 272
Houston 256
Seattle 239
The Dalles 235
Los Angeles 226
Woodbridge 209
Princeton 203
Beijing 202
Lauterbourg 195
Lawrence 182
San Mateo 176
Moscow 167
Cambridge 148
Milan 139
Ann Arbor 129
Hefei 126
Chicago 121
Helsinki 120
Abidjan 115
Centro 112
São Paulo 111
Rome 85
Buffalo 84
Ancona 81
San Diego 80
Phoenix 79
Santa Clara 79
Munich 74
Redmond 74
Orem 70
Turin 70
Da Nang 57
Haiphong 56
Denver 48
London 47
Marche 46
Salt Lake City 45
Montreal 41
Pune 41
Shanghai 41
Toronto 39
Nuremberg 38
Guangzhou 37
Atlanta 36
Frankfurt am Main 35
Porto 33
Tokyo 33
Warsaw 33
Amsterdam 31
Brooklyn 29
Chennai 28
Naples 27
Norwalk 27
Pianella 27
Stockholm 27
Tashkent 27
Turku 27
Washington 27
Johannesburg 26
Rio de Janeiro 26
Miano 23
Vienna 23
Brussels 22
Baghdad 21
Columbus 21
Elk Grove Village 21
Willemstad 21
Belo Horizonte 20
Boston 20
Guatemala City 20
Mexico City 20
Poplar 20
San Francisco 20
Biên Hòa 19
Brasília 18
Medellín 18
Mumbai 18
Bologna 17
Curitiba 17
Hải Dương 17
Palermo 17
Tampa 16
Hangzhou 15
Philadelphia 15
San José 15
Totale 15.793
Salva come PNG Salva come JPEG
Nome #
The Time Has Come for Targeted Therapies for AML: Lights and Shadows 392
Algoritmi diagnostico-terapeutici in Ematologia 325
Human white adipocytes convert into “rainbow” adipocytes in vitro 275
Infection control in patients with myelodysplastic syndromes who are candidates for active treatment: Expert panel consensus-based recommendations 266
A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation. 236
Human de-differentiated adipocytes show similar properties to bone marrow derived mesenchymal stem cells 228
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 220
Apoptotic mechanism activated by blue light and cisplatinum in cutaneous squamous cell carcinoma cells 214
Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome? 211
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 198
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial. 198
Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study 198
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 185
Adipocytes properties and crosstalk with immune system in obesity-related inflammation. 184
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 183
Nilotinib Treatment of Patients Affected by Chronic Graft-versus-Host Disease Reduces Collagen Production and Skin Fibrosis by Downmodulating the TGF-β and p-SMAD Pathway 180
Glial-like differentiation potential of human mature adipocytes 179
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 177
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 176
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 176
Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes 174
Bone marrow adipose tissue is a unique adipose subtype with distinct roles in glucose homeostasis 172
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 171
Human bone marrow adipocytes maintain the survival and differentiation of hematopoietic stem cells 169
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 169
A real life survey on erytropoietin alpha treatment in a cohort of 1049 low risk MDS patients: an italian MDS registry study 167
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 167
Shaping the Future of Myeloproliferative Neoplasm Therapy: Immune-Based Strategies and Targeted Innovations 165
Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis 165
Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study 164
A 50 Hz magnetic field influences the viability of breast cancer cells 96 h after exposure 164
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma. 162
Bone marrow adipocytes support haematopoietic stem cell survival 161
Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report 161
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation. 159
The exosomal surface phenotype and inflamma-miR cargo correlate with MDS diagnosis 159
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study 158
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 158
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 157
Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes. 156
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 156
High predictive value of the revised international prognostic scoring system (IPSS-R): an external analysis of 646 patients from a multiregional italian MDS registry 155
Biosafety evidence for human dedifferentiated adipocytes 154
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. 153
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia 151
Bone Marrow "Yellow" and "Red" Adipocytes: Good or Bad Cells? 151
Human Mesenchymal Stem Cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion 151
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients. 150
Hematologic reconstitution after PBPC autotransplantation:comparison between programmed-rate freezing and uncontrolled freezing at –80° 149
Plasticity of human dedifferentiated adipocytes toward endothelial cells 147
LATE EFFECTS IN Hodgkin's POPULATION Treated BETWEEN 1980-2005 IN A SINGLE INSTITUTION 146
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 145
A rare case of aCML associated with CNS involvement and with aggressive clinical course 145
MiR-422a promotes adipogenesis via MeCP2 downregulation in human bone marrow mesenchymal stem cells 145
Targeting the immune system in MDS and MPN: Understanding the immunome and response to immunotherapy - Part 2 144
Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate 143
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA. 143
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell trasplantation 142
Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications 142
Screening of psychological distress in oncology and hematology department at Ospedali Riuniti Ancona 141
Hematologic reconstitution after PBPC autotransplantation: comparison between programmed-rate freezing and uncontrolled-rate freezing at -80 degrees C 140
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 140
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 140
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression 138
Molecular and functional characterization of human bone marrow adipocytes 137
Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: results from the multicenter FISM BIOFER study 136
NOVELTIES ON MULTIPLE MYELOMA FROM THE MAIN 2024 HEMATOLOGY CONFERENCES 135
Efficacy and safety of eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: interim analysis of a prospective, randomized, single-blind, placebo-controlled trial (EQoL-MDS) 135
Bone Marrow Adipose Tissue 134
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 134
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 133
Novel Translational Read-Through–Inducing Drugs as A Therapeutic Option for Shwachman-Diamond Syndrome 133
Identification of different adypocytes populations within human marrow microenvironment 131
Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study 130
AMIFOSTINE CAN REDUCE MUCOSAL DAMAGE AFTER HIGH-DOSE MELPHALANCONDITIONING FOR PERIPHERAL BLOOD PROGENITOR CELL AUTOTRANSPLANT: A RETROSPECTIVE STUDY. EFFECT OF AMIFOSTINE ON MUCOSITIS DURING AUTOLOGOUS PBPC TRANSPLANTATION 129
A Real Life Survey On Erythropoietin Alpha Treatment In a Cohort Of 1049 Low Risk MDS Patients: An Italian MDS Registry Study 129
History and scientific production of clinica medica and clinica ematologica in ancona 129
Chronic Myelomonocytic Leukemia Diagnosis By Flow Cytometry: An Italian Center Experience 127
Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders. 127
Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow 126
Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta. 125
Accuracy of bone marrow histochemical TP53 expression compared to the detection of TP53 somatic mutations in patients with myelodysplastic syndromes harbouring a del5q cytogenetic abnormality 125
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems 123
mTOR and STAT3 Pathway Hyper-Activation is Associated with evated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment 122
Mesenchymal stem cells of myelodysplastic syndromes show impaired hematopoietic support function and global DNA hypermethylation status 121
Long duration of response to azacitidine in MDS. Multicenter retrospective study of 36 patients 120
CHANGES IN RPS14 EXPRESSION LEVELS DURING LENALIDOMIDE TREATMENT IN LOW- AND INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES WITH CHROMOSOME 5Q DELETION 118
Assessment and monitoring of CMV infection in patients receiving a reduced-intensity conditioning allogeneic transplant: comparison of antigenaemia assay with quantitative PCR 118
Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study 118
Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndrome 117
Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman-Diamond syndrome cells 115
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report 115
AL amyloidosis: an overview on diagnosis, staging system, and treatment 115
DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype 115
Bone Marrow Immunological Changes During Treatment with Lenalidomide In Low and Intermediate-1 Risk Myelodysplastic Syndromes with Del(5Q) 115
TREATMENT WITH AZACITIDINE REVERSES MESENCHYMAL STEM CELLS DERIVED FROM HIGH RISK MYELODYSPLASTIC PATIENTS TO A NORMAL PHENOTYPE 115
Prognostic Factors of Response to Erythropoiesis Stimulating Agents (ESA) Treatment in Non RBC Transfusion Dependent Lower Risk MDS. Preliminary Results of a French and Italian Study (on behalf of the GFM and FISM) 115
Reporting Guidelines, Review of Methodological Standards, and Challenges Toward Harmonization in Bone Marrow Adiposity Research. Report of the Methodologies Working Group of the International Bone Marrow Adiposity Society 115
Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma Treatment 114
QUALITY OF LIFE ASSESSMENT IN PATIENTS AFFECTED BY MYELODYSPLASTIC SYNDROME 114
Totale 15.650
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.405
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.405
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022928 0 0 0 0 10 80 68 111 91 131 136 301
2022/20232.479 225 241 208 188 155 516 2 120 584 10 184 46
2023/20241.626 228 49 87 233 254 371 42 35 5 56 33 233
2024/20253.608 357 318 141 61 131 101 305 101 859 262 338 634
2025/20269.494 630 737 687 1.054 892 658 1.703 933 734 730 296 440
2026/20272.947 505 564 483 1.360 35 0 0 0 0 0 0 0
Totale 26.979